Infections in infancy and the presence of antinuclear antibodies in adult life

Lupus

Volumn 15, Issue 4, 2006, Pages 213-217

  Edwards, C J ^a,b   Syddall, H ^a   Goswami, R ^b   Goswami, P ^b   Dennison, E M ^a,b   Cooper, C ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Antinuclearantibodies; Autoantibodies; Autoimmunity; Environment; Infection; Virus

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; HUMAN; IMMUNOFLUORESCENCE TEST; INFANT; INFECTION RISK; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MALE; MUMPS; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; RUBELLA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; BODY SIZE; COHORT STUDIES; COMMUNICABLE DISEASES; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; INFANT; MALE;

EID: 33646261183     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203306lu2286oa     Document Type: Article

References (34)

1. Lawrence JS, Martins CL, Drake GL. A family survey of lupus erythematosus. 1. Heritability. J Rheumatol 1987; 14: 913-921.
2. Jacobsson LT, Jacobsson ME, Askling J, Knowler WC. Perinatal characteristics and risk of rheumatoid arthritis. Brit Med J 2003; 326: 1068-1069.
3. Edwards CJ, Goswami R, Goswami P et al. Growth and infectious exposure in infancy and the risk of rheumatoid factor in adult life. Ann Rheum Dis 2005.
4. Giles I, Isenberg DA. Antinuclear antibodies: an overview. In Wallace DJ, Hahn BH, eds. Dubois' lupus erythematosus, 6th edn. Lippincott Williams & Wilkins, 2002: 415-424.
5. Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526-1533.
6. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-1611.
7. McKinney PA, Okasha M, Parslow RC et al. Early social mixing and childhood Type 1 diabetes mellitus: a case-control study in Yorkshire, UK. Diabet Med 2000; 17: 236-242.
8. Moudgil KD, Kim E, Yun OJ, Chi HH, Brahn E, Sercarz EE. Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol 2001; 166: 4237-4243.
9. Stene LC, Magnus P, Lie RT, Sovik O, Joner G. Maternal and paternal age at delivery, birth order, and risk of childhood onset type 1 diabetes: population based cohort study. Brit Med J 2001; 323: 69.
10. Tzaneva V, Iotova V, Yotov Y. Significant urban/rural differences in the incidence of type 1 (insulin-dependent) diabetes mellitus among Bulgarian children (1982-1998). Pediatr Diabetes 2001; 2: 103-108.
11. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-1611.
12. Nielen MM, van Schaardenburg D, Reesink HW et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380-386.
13. Walker-Bone K, Edwards CJ, Cooper C. Rheumatoid factor status in adult life is predicted by growth and exposure to infections during the first year of life. Brit Med J rapid responses, 2004. http://bmj.com/cgi/eletters/326/7398/ 1068
14. Forslid J, Heigl Z, Jonsson J, Scheynius A. The prevalence of antinuclear antibodies in healthy young persons and adults, comparing rat liver tissue sections with HEp-2 cells as antigen substrate. Clin Exp Rheumatol 1994; 12: 137-141.
15. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997; 40: 1601-1611.
16. Emlen W, O'Neill L. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays. Arthritis Rheum 1997; 40: 1612-1618.
17. Syddall HE, Sayer AA, Dennison EM, Martin HJ, Barker DJ, Cooper C. Cohort profile: The Hertfordshire Cohort Study. Int J Epidemiol 2005; 34: 1234-1242.
18. Phillips DI, Cooper C, Fall C et al. Fetal growth and autoimmune thyroid disease, Q J Med 1993; 86: 247-253.
19. Breban MA, Moreau MC, Fournier C, Ducluzeau R, Kahn MF. Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol 1993; 11: 61-64.
20. Moudgil KD, Kim E, Yun OJ, Chi HH, Brahn E, Sercarz EE. Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol 2001; 166: 4237-4243.
21. Greenwood BM, Voller A. Suppression of autoimmune disease in New Zealand mice associated with infection with malaria. I. (NZB × NZW) F1 hybrid mice. Clin Exp Immunol 1970; 7: 793-803.
22. Oldstone MB, Dixon FJ. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus. Science 1972; 175: 784-786.
23. Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the "prevalence gradient hypothesis". Arthritis Rheum 1998; 41: 2091-2099.
24. Solomon L, Robin G, Valkenburg HA. Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis 1975; 34: 128-135.
25. Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 1994; 21: 302-306.
26. Edwards CJ, Lian TY, Badsha H, Teh CL, Arden N, Chng HH. Hospitalization of individuals with systemic lupus erythematosus: characteristics and predictors of outcome. Lupus 2003; 12: 672-676.
27. James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB. An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 1997; 100: 3019-3026.
28. James JA, Neas BR, Moser KL et al. Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure. Arthritis Rheum 2001; 44: 1122-1126.
29. McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 2005; 11: 85-89.
30. Benn CS, Melbye M, Wohlfahrt J, Bjorksten B, Aaby P. Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. Brit Med J 2004; 328: 1223.
31. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 1976; 34: 550-557.
32. Kojima A, Tanaka-Kojima Y, Sakakura T, Nishizuka Y. Spontaneous development of autoimmune thyroiditis in neonatally thymectomized mice. Lab Invest 1976; 34: 550-557.
33. Sakaguchi N, Sakaguchi S. Causes and mechanism of autoimmune disease: cyclosporin A as a probe for the investigation. J Invest Dermatol 1992; 98 (Suppl): 70S-76S.
34. McDade TW, Beck MA, Kuzawa C, Adair LS. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence. Am J Clin Nutr 2001; 74: 543-548.